Physician profile
Daniel D Snavely
NPI 1972544047
$119,527.60
in general payments reported to CMS, 2019-2025
46 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $8,813 · 2021: $7,658 · 2022: $29K · 2023: $14K · 2024: $12K · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $6,161 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,750 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,790.00 |
| Food and Beverage | $6,161.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,750.00 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $79,560.06 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $15,754.52 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Novartis Pharmaceuticals Corporation | $10,062.22 | 2019-2025 | |
| Medtronic, INC. | $4,127.58 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Hawkone |
| Zoll Circulation INC | $1,350.00 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Medtronic Vascular, INC. | $805.56 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $784.84 | 2019-2025 | Lifevest |
| Terumo Medical Corporation | $778.24 | 2019-2025 | Glidewire, Glidesheath Slender, Metacross Otw |
| Boston Scientific Corporation | $608.71 | 2019-2024 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Rotapro |
| Edwards Lifesciences Corporation | $605.14 | 2019-2025 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals Lp | $603.02 | 2019-2024 | Wainua, Lokelma |
| Bard Peripheral Vascular, INC. | $512.33 | 2019-2023 | Rotarexs 6 F X 135 Cm, Crosser Iq |
| Heartflow, INC. | $462.90 | 2021-2025 | Ffrct |
| Penumbra, INC. | $456.89 | 2021-2025 | Indigo System |
| Abbott Laboratories | $381.90 | 2019-2025 | Pressurewire, Mitraclip |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $284.48 | 2019-2023 | Otezla, Repatha |
| Pfizer INC. | $273.32 | 2022-2025 | |
| Cardiovascular Systems INC. | $240.89 | 2019-2023 | Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.55 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $187.60 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $184.66 | 2019 | |
| Impulse Dynamics (USA) INC. | $182.62 | 2023 | Optimizer |
| Cvrx, INC. | $146.80 | 2024 | Barostim Neo System |
| Abbvie INC. | $131.94 | 2021-2024 | Vraylar |
| Esperion Therapeutics, INC. | $124.46 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.96 | 2019-2020 | |
| Vifor Pharma, INC. | $62.95 | 2021-2023 | Korsuva, Veltassa |
| Chiesi USA, INC. | $61.14 | 2020-2025 | Kengreal |
| Reflow Medical INC | $58.17 | 2025 | |
| Amarin Pharma, INC. | $54.78 | 2019 | |
| Allergan, INC. | $45.93 | 2019 | |
| Lilly USA, LLC | $44.01 | 2022-2023 | Jardiance, Emgality |
| Endologix LLC | $40.11 | 2025 | Torus Stent Graft System, Endocross Device |
| Cardiva Medical, INC. | $32.97 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Otsuka America Pharmaceutical, INC. | $31.31 | 2022-2023 | Jynarque |
| Novo Nordisk INC | $28.66 | 2020-2021 | |
| Daiichi Sankyo INC. | $21.33 | 2022 | |
| Merck Sharp & Dohme LLC | $17.85 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $16.36 | 2022 | |
| Organon LLC | $16.07 | 2023 | Renflexis, Ontruzant |
| Angiodynamics, INC. | $15.65 | 2019 | |
| Phathom Pharmaceuticals, INC. | $14.28 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $13.85 | 2022 | |
| Cardiofocus, INC. | $13.59 | 2019 | |
| Gilead Sciences, INC. | $12.09 | 2019 | |
| Lundbeck LLC | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Snavely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.